Fingerpaint, a full-service health and wellness marketing agency, executed a strategic investment in Leaderboard Branding, a leading global naming and branding business headquartered in Charlotte, N.C., to grow its portfolio of companies.

Basel-based Lonza AG is moving to sell the company’s Lonza Specialty Ingredients division to private equity firms Bain Capital and Cinven for CHF 4.2 billion ($4.7 billion), completing a planned pivot to focus on Lonza Pharma, Biotech & Nutrition business. 

Data-driven marketing products and services communications firm Relevate Health Group announced the completion of a strategic combination with Arteric, a digital marketing agency known for its proprietary machine learning (ML) driven multichannel digital marketing.

Caris Life Sciences secured $310 million in growth capital that will be used to expand the molecular science company’s presence in precision medicine in oncology.

Walgreens Boots Alliance is partnering with primary care provider VillageMD to open doctor offices attached to the pharmacy chain’s drugstores across the United States.

The Wall Street Journal reported that Theranos Inc. secured a loan from Fortress Investment Group.

Valeant Pharmaceuticals is selling its Obagi Medical Products business to Haitong International Zhonghua Finance Acquisition Fund I for $190 million in cash.

Valeant Pharmaceuticals is selling off its equity interests in Dendreon Pharmaceuticals Inc. to China’s Sanpower Group Co. Ltd. for about $820 million.

London-listed pharma firm Shire said its dry-eye disease drug lifitegrast significantly improved patient symptoms in a new study, supporting a re-submission of the potentially block-busting medicine to U.S. regulators early next year. Shares in Shire jumped more than 6 percent after it announced the positive results of the study on Tuesday. They were trading up […]